Protective effect of galanin on behavioral deficits in experimental traumatic brain injury

S. Liu, Bruce G Lyeth, R. J. Hamm

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The magnitude of behavioral deficits in traumatic brain injury (TBI) has been shown to be partly related to alterations in the balance between excitatory and inhibitory neurotransmitter release. Previous studies have demonstrated that extracellular excitatory neurotransmitter concentrations dramatically increase following experimental TBI. We examined the effects of a neuromodulatory peptide, galanin (GAL), on behavioral morbidity, as measured by sensory motor and memory performance tasks, associated with experimental TBI in the rat. A single intraventricular injection of GAL (1.0 μg, n = 8 or 10.0 μg, n = 10) or cerebrospinal fluid (CSF) vehicle (n = 10) was administered 5 minutes prior to central fluid percussion TBI in rats. Performance on sensory motor tasks was assessed prior to injury and for 5 days after TBI with beam-balance, beam-walking, and rotarod tasks. Memory performance was assessed on days 11-15 after TBI with the Morris water maze. TBI produced significant motor and memory deficits in the CSF-treated group. GAL-treated rats had significantly less magnitude of deficits compared to CSF-treated rats on beam-balance, beam-walking, and rotarod performance. The 1.0 μg GAL dose produced slightly greater protection than the 10.0 μg GAL dose. Neither GAL dose affected body weight loss or Morris water maze performance. These results suggest that the physiologic effects of GAL may reduce certain components of TBI morbidity, possibly by modulating neuronal excitability.

Original languageEnglish (US)
Pages (from-to)73-82
Number of pages10
JournalJournal of Neurotrauma
Volume11
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Galanin
Psychomotor Performance
Cerebrospinal Fluid
Walking
Neurotransmitter Agents
Intraventricular Injections
Morbidity
Percussion
Traumatic Brain Injury
Water
Memory Disorders
Weight Loss
Body Weight
Peptides
Wounds and Injuries

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Protective effect of galanin on behavioral deficits in experimental traumatic brain injury. / Liu, S.; Lyeth, Bruce G; Hamm, R. J.

In: Journal of Neurotrauma, Vol. 11, No. 1, 1994, p. 73-82.

Research output: Contribution to journalArticle

@article{f067ccb293d64f0d8e7a956d0b3269dc,
title = "Protective effect of galanin on behavioral deficits in experimental traumatic brain injury",
abstract = "The magnitude of behavioral deficits in traumatic brain injury (TBI) has been shown to be partly related to alterations in the balance between excitatory and inhibitory neurotransmitter release. Previous studies have demonstrated that extracellular excitatory neurotransmitter concentrations dramatically increase following experimental TBI. We examined the effects of a neuromodulatory peptide, galanin (GAL), on behavioral morbidity, as measured by sensory motor and memory performance tasks, associated with experimental TBI in the rat. A single intraventricular injection of GAL (1.0 μg, n = 8 or 10.0 μg, n = 10) or cerebrospinal fluid (CSF) vehicle (n = 10) was administered 5 minutes prior to central fluid percussion TBI in rats. Performance on sensory motor tasks was assessed prior to injury and for 5 days after TBI with beam-balance, beam-walking, and rotarod tasks. Memory performance was assessed on days 11-15 after TBI with the Morris water maze. TBI produced significant motor and memory deficits in the CSF-treated group. GAL-treated rats had significantly less magnitude of deficits compared to CSF-treated rats on beam-balance, beam-walking, and rotarod performance. The 1.0 μg GAL dose produced slightly greater protection than the 10.0 μg GAL dose. Neither GAL dose affected body weight loss or Morris water maze performance. These results suggest that the physiologic effects of GAL may reduce certain components of TBI morbidity, possibly by modulating neuronal excitability.",
author = "S. Liu and Lyeth, {Bruce G} and Hamm, {R. J.}",
year = "1994",
language = "English (US)",
volume = "11",
pages = "73--82",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Protective effect of galanin on behavioral deficits in experimental traumatic brain injury

AU - Liu, S.

AU - Lyeth, Bruce G

AU - Hamm, R. J.

PY - 1994

Y1 - 1994

N2 - The magnitude of behavioral deficits in traumatic brain injury (TBI) has been shown to be partly related to alterations in the balance between excitatory and inhibitory neurotransmitter release. Previous studies have demonstrated that extracellular excitatory neurotransmitter concentrations dramatically increase following experimental TBI. We examined the effects of a neuromodulatory peptide, galanin (GAL), on behavioral morbidity, as measured by sensory motor and memory performance tasks, associated with experimental TBI in the rat. A single intraventricular injection of GAL (1.0 μg, n = 8 or 10.0 μg, n = 10) or cerebrospinal fluid (CSF) vehicle (n = 10) was administered 5 minutes prior to central fluid percussion TBI in rats. Performance on sensory motor tasks was assessed prior to injury and for 5 days after TBI with beam-balance, beam-walking, and rotarod tasks. Memory performance was assessed on days 11-15 after TBI with the Morris water maze. TBI produced significant motor and memory deficits in the CSF-treated group. GAL-treated rats had significantly less magnitude of deficits compared to CSF-treated rats on beam-balance, beam-walking, and rotarod performance. The 1.0 μg GAL dose produced slightly greater protection than the 10.0 μg GAL dose. Neither GAL dose affected body weight loss or Morris water maze performance. These results suggest that the physiologic effects of GAL may reduce certain components of TBI morbidity, possibly by modulating neuronal excitability.

AB - The magnitude of behavioral deficits in traumatic brain injury (TBI) has been shown to be partly related to alterations in the balance between excitatory and inhibitory neurotransmitter release. Previous studies have demonstrated that extracellular excitatory neurotransmitter concentrations dramatically increase following experimental TBI. We examined the effects of a neuromodulatory peptide, galanin (GAL), on behavioral morbidity, as measured by sensory motor and memory performance tasks, associated with experimental TBI in the rat. A single intraventricular injection of GAL (1.0 μg, n = 8 or 10.0 μg, n = 10) or cerebrospinal fluid (CSF) vehicle (n = 10) was administered 5 minutes prior to central fluid percussion TBI in rats. Performance on sensory motor tasks was assessed prior to injury and for 5 days after TBI with beam-balance, beam-walking, and rotarod tasks. Memory performance was assessed on days 11-15 after TBI with the Morris water maze. TBI produced significant motor and memory deficits in the CSF-treated group. GAL-treated rats had significantly less magnitude of deficits compared to CSF-treated rats on beam-balance, beam-walking, and rotarod performance. The 1.0 μg GAL dose produced slightly greater protection than the 10.0 μg GAL dose. Neither GAL dose affected body weight loss or Morris water maze performance. These results suggest that the physiologic effects of GAL may reduce certain components of TBI morbidity, possibly by modulating neuronal excitability.

UR - http://www.scopus.com/inward/record.url?scp=0028212728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028212728&partnerID=8YFLogxK

M3 - Article

C2 - 7515444

AN - SCOPUS:0028212728

VL - 11

SP - 73

EP - 82

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 1

ER -